Skip to main content

Grandma and BR, shut the fuck up!

LiHub is now officially a Yahoo cesspool with two complete assholes masterbating publicly 24/7. Fucking unbelievable.

TC

Comments

  1. vidpok45September 8, 2017 at 7:21 PM

    TC, please dont hold back, tell us what you really think lol. Fwiw, you are 1000 percent correct imho.

    ReplyDelete
    Replies
    1. Trading CyclistSeptember 8, 2017 at 7:27 PM

      I'll confess I might have been a bit too restrained, and will be more forthright in the future.

      Delete
    2. YorkTigerSeptember 9, 2017 at 6:43 PM

      Grandma caused me to delete the iHub app. Something is not right with that person. I stick to StockTwits now. iHub is unusable.

      Delete
    3. UnknownSeptember 11, 2017 at 4:51 AM

      Aurinia Pharmaceuticals Inc
      Ban List
      Member: grandma_of_jbraika
      Date Banned: 09/10/2017 09:35:33 AM
      Banned By: IH Admin [Edward]
      Banned Until: Further Notice

      Delete
  2. vidpok45September 11, 2017 at 5:22 AM

    Looks like asshole number 1 was banned from Ihub (grandma). Now they should ban asshole number 2: BR

    ReplyDelete
  3. vidpok45September 12, 2017 at 8:03 AM

    Still a buyer in the 5's

    ReplyDelete
  4. vidpok45September 20, 2017 at 6:50 AM

    Apparently there are multiple indications coming in October. This may be the last time to get in low before the sp begins its ascent.

    ReplyDelete

Post a Comment

Popular posts from this blog

June 6, 2017. Buy Out at 63?

Take a spin on our BO pricing model! The Trading Cyclist Our model is generating a range of $35-63 BO PPS , per the low/high case scenarios below - where only the Voc  price  is different (25 k vs 50k). My hunch is that this is both conservative and in the ballpark.  It's conservative b/c: 1) patient population is consistent with Aurinia's projection; 2) assumes only 35% of population on treatment; 3) assumes 75% discount for European market; 4) pricing is at 50% of range projected by Aurinia; 5) uses target P/S ratio of 3, which is below Biotech industry average of 5.0.  Outcome   Patient Pool  (Same for both Scenarios)  Pricing :  Price/Sales ratio   Here's the  Link to the model Low end BO PPS w/30% discount:  $35  ($50 no discount)  High End BO PPS w/30% discount  $63  ($90 no discount)  Prev: 26.5 per 100,000 (Based on epidemiological study)  Total Patient po...
25 comments
Read more

June 8, 2017: The case for early approval of Voclosporin

Voclosporin will likely be approved well before the P3 trial runs it course. Here's how it's going to work.  First, there's a legal and regulatory path for this approval .  While I quote the relevant passage below, here's the link to the  FDA Regulations , as well as  a   list of drugs   t hat received accelerated approval.  Sec. 314.510 Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidity. FDA may grant marketing approval for a new drug product on the basis of adequate and well-controlled clinical trials establishing that the drug product has an effect on a surrogate endpoin t that is reasonably likely, based on epidemiologic, therapeutic, pathophysiologic, or other evidence, to predict clinical benefit or on the basis of an effect on a clinical endpoint other than survival or irreversible morbidity. Approval under this section will be subject to the requirement that ...
16 comments
Read more

iHub has been hijacked by trolls

Yup. iHub can't get rid of "Biotech Researcher," aka BR.  It's both a win for BR (the troll), and a huge loss for iHub. Their platform loses value and credibility when they refuse to take action on perma-trolls that derail the discussion and distract investors from their efforts to just honestly share information and opinions on the equities they own. So shame on iHub for not taking action to resolve this. I'm going to cease and desist on posting there until the troll (BR) problem has been resolved, and credible, valuable posters have been reinstated. I've already cancelled my premium membership some time ago. I suggest you do the same. With kind regards to all Trading Cyclist (aka TC)
53 comments
Read more